| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6114219 | Transfusion and Apheresis Science | 2013 | 6 Pages |
Abstract
In conclusion, this study confirmed that there were not clinically relevant intergroup (pre-storage vs. post-storage PRT-treatment) differences in plasma constituent levels. Post-storage treated FFP remains, protein quantity, and activity well, and therefore can be used in clinical practice. Previously cryostored or quarantine FFP units (despite the reduced quarantine period after NAT/PCR testing) could be safely and effectively inactivated, directly prior to clinical application.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Bela Balint, Dragana Jovicic-Gojkov, Milena Todorovic-Balint, Vesna Subota, Mirjana Pavlovic, Raymond Goodrich,